Global Generic Drug Market Size, Share, Demand by Region, Growth, Revenue Status & Forecast by 2023by Rahul Rastogi Market Research Analyst
IMARC group has recently broadcasted a new study to its broad research portfolio, which is titled as “Generic Drugs Market: Global Industry Trends, Manufacturing Process, Share, Size, Growth, Opportunity and Forecast 2018-2023” provides an in-depth analysis of the global generic drug market forecast with the market size and growth. The report studies the casing heads market worldwide, especially in United States, China, Brazil, Germany, France, India, United Kingdom, Japan, Canada and Italy with production, size, growth, revenue, consumption, import and export in these regions.
Request a Free Sample Report: https://www.imarcgroup.com/request?type=report&id=549&flag=B
The global generic drugs market was worth around US$ 315 Billion in 2017, exhibiting a CAGR of 6.7% during 2010-2017. The market is further projected to reach a value of US$ 474 Billion by 2023, at a CAGR of 6.8% during 2018-2023. Generic drugs are bioequivalents of brand-name drugs in terms of strength, quality, dosage, form, effect, side effect, intended use and route of administration. Generally, pharmaceutical companies spend a huge amount of money on the marketing of innovator drugs as they have to educate both the physicians and authorities on the efficacy and safety profile of the new drug. As generics do not require such extensive marketing to establish their safety and efficacy, they offer higher profit margins to the manufacturers.
Table of Content:
2 Research Methodology
3 Executive Summary
4.2 Key Industry Trends
5 Global Generic Drug Industry
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Country
5.4 Market Breakup by Therapy Area
5.5 Market Breakup by Drug Delivery
5.6 Market Breakup by Distribution Channel
5.7 Market Forecast
5.8 SWOT Analysis
5.9 Value Chain Analysis
5.9.1 Research and Development
5.9.3 Marketing and Distribution
5.10 Porter’s Five Forces Analysis
5.10.2 Bargaining Power of Buyers
5.10.3 Bargaining Power of Suppliers
5.10.4 Degree of Competition
5.10.5 Threat of New Entrants
5.10.6 Threat of Substitutes
5.11 Regulations in the Generic Industry
5.12 Key Market Drivers and Success Factors
… List of Figure
Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/generic-drug-manufacturing-plant
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Tel No:(D) +91 120 433 0800 |
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331
Created on Feb 5th 2019 06:33. Viewed 500 times.